Lena Hjelte

Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR : a randomised, placebo-controlled phase 3 trial

Félix Ratjen, Christopher Hug, Gautham Marigowda et al. · The Lancet Respiratory Medicine · 2017 · 291 citations

Pulmonary Fibrosis, Medicine, Placebo-controlled Phase 3

Pulmonary exacerbation: Towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials

Diana Bilton, G. Canny, Sigitas Dumčius et al. · Journal of Cystic Fibrosis · 2011 · 200 citations · Full text

Acute Lung Injury, Pulmonary Care, Advanced Lung Disease +12

Predictors of deterioration of lung function in cystic fibrosis*

Charlotta Schaedel, Isabelle de Monestrol, Lena Hjelte et al. · Pediatric Pulmonology · 2002 · 181 citations

Delayed Puberty in Girls With Cystic Fibrosis Despite Good Clinical Status

Marie Johannesson, C. Gottlieb, Lena Hjelte · PEDIATRICS · 1997 · 116 citations

Prospective study of mycobacterial infections in patients with cystic fibrosis.

Lena Hjelte, B Petrini, Gunilla Källenius et al. · Thorax · 1990 · 100 citations · Full text

Fifty Four, Pulmonary Tuberculosis, Microbial Disease +11